Displaying 81 - 100 of 459
FTC Returns Nearly $60 Million to Those Suffering from Opioid Addiction Who Were Allegedly Overcharged in Suboxone Film Scheme
Agency Information Collection Activities; Submission for OMB Review; Comment Request (Wool Rules)
Agency Information Collection Activities; Submission for OMB Review; Comment Request (Care Labeling Rule)
FTC Approves Final Order Requiring Gennex Media LLC and Owner to Pay Monetary Judgment and Stop Making Deceptive Claims
Gennex Media, In the Matter of
Gennex Media LLC, which sells customizable promotional products such as wristbands, lanyards, temporary tattoos, and buttons, and its owner, Akil Kurji, will settle FTC charges that they made false, misleading, or unsupported advertising claims that their “Brandnex” products were all or virtually all made in the United States. The complaint alleges Gennex and Kurji violated the FTC Act by claiming on their Brandnex website that the products they sell are made in the United States, when in numerous instances the products are wholly imported from China. Under the proposed settlement, Gennex and Kurji are prohibited from making the deceptive claims alleged in the complaint and are required to pay a monetary judgment of $146,249.24. On April 14, 2021, the Commission announced the final consent agreement in this matter.
U.S. Court of Appeals for the Fifth Circuit Upholds FTC’s Opinion against Generic Pharmaceutical Company Impax Laboratories, LLC
FTC Announces Multilateral Working Group to Build a New Approach to Pharmaceutical Mergers
Gennex Media LLC; Analysis of Proposed Consent Order To Aid Public Comment
FTC Order Requires Gennex Media LLC and Its Owner to Pay $146,249, and Stop Making Deceptive ‘Made in USA’ Claims
FTC Approves Final Order Stopping the Manufacturer of Superglues, and Company President, from Marketing Products with Misleading ‘Made in USA’ Claims
Agency Information Collection Activities; Proposed Collection; Comment Request; Extension (Wool Rules)
Following Federal Trade Commission Staff Recommendation to Challenge Transaction, Tronox Holding plc. Abandons Proposed Acquisition of TiZir Titanium and Iron
FTC Approves Final Order Imposing Conditions on Combination of Pfizer Inc.’s Upjohn and Mylan N.V.
Pfizer/Mylan, In the Matter of
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.
Agency Information Collection Activities; Submission for OMB Review; Comment Request (R-value Rule)
Procter & Gamble Co. and Billie, Inc., In the Matter of
The Federal Trade Commission filed an administrative complaint and authorized a suit in federal court to block The Procter & Gamble Company’s proposed acquisition of Billie, Inc., a direct-to-consumer company that began selling women’s razors and body care products in November 2017. The complaint alleged that the proposed acquisition would allow P&G, the market-leading supplier of both women’s and men’s wet shave razors, to buy Billie, a newer but expanding maker of women’s razors, and thereby eliminate growing competition that benefits consumers. On Jan. 5, 2021, the parties announced that they terminated their agreement for P&G to acquire Billie.
Statement of Ian Conner, Director of the FTC’s Bureau of Competition, Regarding the Announcement that The Procter & Gamble Company has Abandoned Its Proposed Acquisition of Billie, Inc.
Displaying 81 - 100 of 459